Skip to main content
. 2022 Dec 12;16(1):136–142. doi: 10.1016/j.jiph.2022.12.009

Table 1.

Demographic and clinical parameters of patients included in the study.

Number of patients with data available
Males, n° (%) 321 218(67.9)
Age, years, mean (SD) 321 65(14.25)
Days from symptoms to admission, median (Q1-Q3) 213 6(2–9)
Charlson comorbidity index, mean (SD) 317 3(1–4)
n° (%) with hypertension 316 165(52.2)
n° (%) with cardio-vascular disease 316 101(32)
n° (%) with diabetes 316 77(24.4)
n° (%) with chronic kidney disease 317 24(7.6)
n° (%) with chronic obstructive pulmonary disease 316 26(8.2)
n° (%) with chronic hepatopathy 316 13(4.0)
n° (%) with malignancy 315 22(6.9)
n° (%) with dementia 316 12(3.7)
n° (%) with fever during recent history 320 184(57.5)
n° (%) with dyspnea during recent history 320 236(73.8)
n° (%) with astheny during recent history 320 97(30.3)
n° (%) with cough during recent history 320 107(33.4)
n° (%) with ageusia/dysgeusia during recent history 319 4(1.3)
n° (%) with anosmia/hyposmia during recent history 319 5(1.6)
n° (%°) with diarrhoea during recent history 319 9(2.8)
n° (%) with skin lesions during recent history 318 0(0)
Days from admission to discharge*, mean (SD) 318 12(7–17)
Patients with mild or moderate outcome, n° (%) 321 184(57.3)
Patients with severe outcome or who died during hospitalization, n° (%) 321 137(42.7)
n° (%) patients who died during hospitalization 321 48(15)
CT score, mean (SD) 321 13.05(4.79)
*

or who died during hospitalization